Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial

著者: Stefan James, Axel Åkerblom, Christopher P. Cannon, Håkan Emanuelsson, Steen Husted, Hugo A. Katus, Allan M. Skene, Philippe Gabríel Steg, Robert F. Storey, Robert A. Harrington, Richard C. Becker, Lars Wallentin - American Heart Journal 2009 被引用: 402